An Updated Review of Implantable Cardioverter/Defibrillators, Induced Anxiety, and Quality of Life

Psychiatric Clinics of North America

Volumn 30, Issue 4, 2007, Pages 677-688

  Bostwick, J Michael ^a   Sola, Christopher L ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANXIOLYTIC AGENT; BENZODIAZEPINE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ANXIETY DISORDER; CLINICAL ASSESSMENT; CLINICAL ASSESSMENT TOOL; DEFIBRILLATOR; HEALTH CARE COST; HEART VENTRICLE ARRHYTHMIA; HUMAN; MENTAL DISEASE; PAIN; PERCEPTION; PERSONALITY; PREDICTION; PRIORITY JOURNAL; PSYCHOEDUCATION; PSYCHOTHERAPY; QUALITY OF LIFE; REVIEW; SCORING SYSTEM; SEX DIFFERENCE; SHOCK; SOCIAL SUPPORT; UNSPECIFIED SIDE EFFECT;

ANGER; ANXIETY DISORDERS; ATTITUDE TO HEALTH; COGNITIVE THERAPY; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; FAMILY; HUMANS; PERIODICITY; QUALITY OF LIFE; QUESTIONNAIRES; SOCIAL SUPPORT;

EID: 35148824661     PISSN: 0193953X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psc.2007.07.002     Document Type: Review

References (58)

1. DiMarco J.P. Implantable cardioverter-defibrillators. N Engl J Med 349 19 (2003) 1836-1847
2. Glikson M., and Friedman P.A. The implantable cardioverter defibrillator. Lancet 357 9262 (2001) 1107-1117
3. Moss A.J., Hall W.J., Cannom D.S., et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 335 26 (1996) 1933-1940
4. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. The Antiarrhythmics Versus Implantable Defibrillators (AVID) Investigators. N Engl J Med 337 22 (1997) 1576-1583
5. Connolly S.J., Gent M., Roberts R.S., et al. Canadian Implantable Defibrillator Study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 101 11 (2000) 1297-1302
6. Kuck K.H., Cappato R., Siebels J., et al. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH). Circulation 102 7 (2000) 748-754
7. Bokhari F., Newman D., Greene M., et al. Long-term comparison of the implantable cardioverter defibrillator versus amiodarone: eleven-year follow-up of a subset of patients in the Canadian Implantable Defibrillator Study (CIDS). Circulation 110 2 (2004) 112-116
8. Greenberg H., Case R.B., Moss A.J., et al. Analysis of mortality events in the Multicenter Automatic Defibrillator Implantation Trial (MADIT-II). J Am Coll Cardiol 43 8 (2004) 1459-1465
9. Bardy G.H., Lee K.L., Mark D.B., et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352 3 (2005) 225-237
10. U.S. Food and Drug Administration Center for Devices and Radiological Health. Available at: http://www.accessdata.fda.gov/scripts/cdrh/devicesatfda/index.cfm. Accessed June 8, 2007.
11. Vlay S.C. The automatic internal cardioverter-defibrillator: comprehensive clinical follow-up, economic and social impact-the Stony Brook experience. Am Heart J 112 1 (1986) 189-194
12. Luderitz B., Jung W., Deister A., et al. Patient acceptance of the implantable cardioverter defibrillator in ventricular tachyarrhythmias. Pacing Clin Electrophysiol 16 9 (1993) 1815-1821
13. Eads A.S., Sears Jr. S.F., Sotile W.M., et al. Supportive communication with implantable cardioverter defibrillator patients: seven principles to facilitate psychosocial adjustment. J Cardiopulm Rehabil 20 2 (2000) 109-114
14. Kuhl E.A., Dixit N.K., Walker R.L., et al. Measurement of patient fears about implantable cardioverter defibrillator shock: an initial evaluation of the Florida Shock Anxiety Scale. Pacing Clin Electrophysiol 29 6 (2006) 614-618
15. Kamphuis H.C., de Leeuw J.R., Derksen R., et al. Implantable cardioverter defibrillator recipients: quality of life in recipients with and without ICD shock delivery: a prospective study. Europace 5 4 (2003) 381-389
16. Namerow P.B., Firth B.R., Heywood G.M., et al. Quality-of-life six months after CABG surgery in patients randomized to ICD versus no ICD therapy: findings from the CABG Patch Trial. Pacing Clin Electrophysiol 22 9 (1999) 1305-1313
17. Irvine J., Dorian P., Baker B., et al. Quality of life in the Canadian Implantable Defibrillator Study (CIDS). Am Heart J 144 2 (2002) 282-289
18. Sears Jr. S.E., and Conti J.B. Understanding implantable cardioverter defibrillator shocks and storms: medical and psychosocial considerations for research and clinical care. Clin Cardiol 26 3 (2003) 107-111
19. Sola C.L., and Bostwick J.M. Implantable cardioverter-defibrillators, induced anxiety, and quality of life. Mayo Clin Proc 80 2 (2005) 232-237
20. DeMaso D.R., Lauretti A., Spieth L., et al. Psychosocial factors and quality of life in children and adolescents with implantable cardioverter-defibrillators. Am J Cardiol 93 5 (2004) 582-587
21. Crossmann A., Pauli P., Dengler W., et al. Stability and cause of anxiety in patients with an implantable cardioverter-defibrillator: a longitudinal two-year follow-up. Heart Lung 36 2 (2007) 87-95
22. Bilge A.K., Ozben B., Demircan S., et al. Depression and anxiety status of patients with implantable cardioverter defibrillator and precipitating factors. Pacing Clin Electrophysiol 29 6 (2006) 619-626
23. Yarnoz M.J., and Curtis A.B. Why cardioverter-defibrillator implantation might not be the best idea for your elderly patient. Am J Geriatr Cardiol 15 6 (2006) 367-371
24. Hamilton G.A., and Carroll D.L. The effects of age on quality of life in implantable cardioverter defibrillator recipients. J Clin Nurs 13 2 (2004) 194-200
25. Thomas S.A., Friedmann E., Kao C.W., et al. Quality of life and psychological status of patients with implantable cardioverter defibrillators. Am J Crit Care 15 4 (2006) 389-398
26. Walker R.L., Campbell K.A., Sears S.F., et al. Women and the implantable cardioverter defibrillator: a lifespan perspective on key psychosocial issues. Clin Cardiol 27 10 (2004) 543-546
27. Sowell L.V., Kuhl E.A., Sears S.F., et al. Device implant technique and consideration of body image: specific procedures for implantable cardioverter defibrillators in female patients. J Womens Health (Larchmt) 15 7 (2006) 830-835
28. Luyster F.S., Hughes J.W., Waechter D., et al. Resource loss predicts depression and anxiety among patients treated with an implantable cardioverter defibrillator. Psychosom Med 68 5 (2006) 794-800
29. Smith G., Dunbar S.B., Valderrama A.L., et al. Gender differences in implantable cardioverter-defibrillator patients at the time of insertion. Prog Cardiovasc Nurs 21 2 (2006) 76-82
30. Bourke J.P., Turkington D., Thomas G., et al. Florid psychopathology in patients receiving shocks from implanted cardioverter-defibrillators. Heart 78 6 (1997) 581-583
31. Leosdottir M., Sigurdsson E., Reimarsdottir G., et al. Health-related quality of life of patients with implantable cardioverter defibrillators compared with that of pacemaker recipients. Europace 8 3 (2006) 168-174
32. Godemann F., Butter C., Lampe F., et al. Determinants of the quality of life (QoL) in patients with an implantable cardioverter/defibrillator (ICD). Qual Life Res 13 2 (2004) 411-416
33. Newall E.G., Lever N.A., Prasad S., et al. Psychological implications of ICD implantation in a New Zealand population. Europace 9 1 (2007) 20-24
34. Sears S.F., Lewis T.S., Kuhl E.A., et al. Predictors of quality of life in patients with implantable cardioverter defibrillators. Psychosomatics 46 5 (2005) 451-457
35. Pedersen S.S., van Domburg R.T., Theuns D.A., et al. Concerns about the implantable cardioverter defibrillator: a determinant of anxiety and depressive symptoms independent of experienced shocks. Am Heart J 149 4 (2005) 664-669
36. Prudente L.A., Reigle J., Bourguignon C., et al. Psychological indices and phantom shocks in patients with ICD. J Interv Card Electrophysiol 15 3 (2006) 185-190
37. Hoecksel K., and Bostwick J. Getting to the heart of his shocking trauma. Current Psychiatry 6 (2007) 84-91
38. Steinke E.E., Gill-Hopple K., Valdez D., et al. Sexual concerns and educational needs after an implantable cardioverter defibrillator. Heart Lung 34 5 (2005) 299-308
39. Sears Jr. S.F., Stutts L.A., Aranda Jr. J.M., et al. Managing congestive heart failure patient factors in the device era. Congest Heart Fail 12 6 (2006) 335-340
40. Lemon J., Edelman S., and Kirkness A. Avoidance behaviors in patients with implantable cardioverter defibrillators. Heart Lung 33 3 (2004) 176-182
41. Burg M.M., Lampert R., Joska T., et al. Psychological traits and emotion-triggering of ICD shock-terminated arrhythmias. Psychosom Med 66 6 (2004) 898-902
42. Lemon J., and Edelman S. Psychological adaptation to ICDs and the influence of anxiety sensitivity. Psychol Health Med 12 2 (2007) 163-171
43. Sears S.F., Serber E.R., Lewis T.S., et al. Do positive health expectations and optimism relate to quality-of-life outcomes for the patient with an implantable cardioverter defibrillator?. J Cardiopulm Rehabil 24 5 (2004) 324-331
44. Dougherty C.M., Lewis F.M., Thompson E.A., et al. Short-term efficacy of a telephone intervention by expert nurses after an implantable cardioverter defibrillator. Pacing Clin Electrophysiol 27 12 (2004) 1594-1602
45. Sears Jr. S.F., Shea J.B., and Conti J.B. Cardiology patient page. How to respond to an implantable cardioverter-defibrillator shock. Circulation 111 23 (2005) e380-e382
46. Prudente L.A. Psychological disturbances, adjustment, and the development of phantom shocks in patients with an implantable cardioverter defibrillator. J Cardiovasc Nurs 20 4 (2005) 288-293
47. Kuhl E.A., Sears S.F., and Conti J.B. Using computers to improve the psychosocial care of implantable cardioverter defibrillator recipients. Pacing Clin Electrophysiol 29 12 (2006) 1426-1433
48. The Zapper online newsletter. Available at: http://www.zaplife.org/. Accessed June 8, 2007.
49. Johnson B, Francis J. Cognitive behavourial therapy for patients with implantable cardioverter-defibrillators [protocol]. The Cochrane Library, Issue 3, 2007. Available at: http://www.thecochranelibrary.com. Accessed May 29, 2007.
50. Chevalier P., Cottraux J., Mollard E., et al. Prevention of implantable defibrillator shocks by cognitive behavioral therapy: a pilot trial. Am Heart J 151 1 (2006) 191.e1-191.e6
51. Frizelle D.J., Lewin R.J., Kaye G., et al. Cognitive-behavioural rehabilitation programme for patients with an implanted cardioverter defibrillator: a pilot study. Br J Health Psychol 9 Pt 3 (2004) 381-392
52. Belardinelli R., Capestro F., Misiani A., et al. Moderate exercise training improves functional capacity, quality of life, and endothelium-dependent vasodilation in chronic heart failure patients with implantable cardioverter defibrillators and cardiac resynchronization therapy. Eur J Cardiovasc Prev Rehabil 13 5 (2006) 818-825
53. Carnes C.A., Pickworth K.K., Votolato N.A., et al. Elevated defibrillation threshold with venlafaxine therapy. Pharmacotherapy 24 8 (2004) 1095-1098
54. Stutts L.A., Cross N.J., Conti J.B., et al. Examination of research trends on patient factors in patients with implantable cardioverter defibrillators. Clin Cardiol 30 2 (2007) 64-68
55. Sears Jr. S.F., and Conti J.B. Psychological aspects of cardiac devices and recalls in patients with implantable cardioverter defibrillators. Am J Cardiol 98 4 (2006) 565-567
56. van den Broek K.C., Denollet J., Nyklicek I., et al. Psychological reaction to potential malfunctioning of implantable defibrillators. Pacing Clin Electrophysiol 29 9 (2006) 953-956
57. Noyes K., Corona E., Zwanziger J., et al. Health-related quality of life consequences of implantable cardioverter defibrillators: results from MADIT II. Med Care 45 5 (2007) 377-385
58. Frizelle D.J., Lewin B., Kaye G., et al. Development of a measure of the concerns held by people with implanted cardioverter defibrillators: the ICDC. Br J Health Psychol 11 Pt 2 (2006) 293-301